Skip to content

Implementing Pulmonary Rehabilitation in Primary care: Feasibility, acceptability, and safety

Implementing Pulmonary Rehabilitation in Primary care: Feasibility, acceptability, and safety

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622001501730
Acronym
PURE PRIME
Enrollment
72
Registered
2022-12-01
Start date
2023-05-25
Completion date
2025-05-14
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to investigate whether pulmonary rehabilitation (PR) can be conducted in private physiotherapy and exercise physiology practices. The study consists of two parts, part one involves training clinician participants in PR and part two involves provision of PR by those clinicians upskilled in part one to provide PR to patient participants. In part one, clinician participants will undertake a training program in PR. This will be evaluated using short questionnaires and practical assessment of skills, knowledge and confidence before, after and 3-month following the training program. In part two, people with COPD will be randomly allocated to either an 8-week private practice PR program or usual care. We will measure the feasibility to provide PR in this setting as well as measuring clinical outcomes such as exercise capacity and health-related quality of life. Both patient and clinician participants will be invited to complete semi-structured interviews.

Interventions

The aim of this study is to investigate whether upskilling private practice physiotherapists and accredited exercise physiologists (AEP) to provide pulmonary rehabilitation (PR) in the primary care setting is feasible to implement, acceptable to stakeholders and effective in achieving the known beneficial outcomes of PR. The study consists of two parts. Part one: Clinician participants will be given access to the Lung Foundation Australia Pulmonary Rehabilitation Online Training Program. The p

The aim of this study is to investigate whether upskilling private practice physiotherapists and accredited exercise physiologists (AEP) to provide pulmonary rehabilitation (PR) in the primary care setting is feasible to implement, acceptable to stakeholders and effective in achieving the known beneficial outcomes of PR. The study consists of two parts. Part one: Clinician participants will be given access to the Lung Foundation Australia Pulmonary Rehabilitation Online Training Program. The program is a 6-8 hour online training program that aims to increase the knowledge and confidence of health professionals to deliver evidence-based PR. The course includes modules on: • Establishing a pulmonary rehabilitation program • The respiratory system and COPD • Comprehensive patient assessment • Patient assessment – Spirometry • Patient assessment – Assessing exercise capacity • Patient Assessment – Quality of life • Exercise training • Patient education • Program evaluation and troubleshooting The online training will be delivered online on a learning platform with interactive infographics, text and animation. Participants will complete the course at their own pace within the 3 weeks prior to their practical module. The program duration is approximately 6-8 hours. Completion of modules will be monitored by the learning platform analytics. After completion of the online training program, participants will attend a practical face-to-face module. Attendance will be monitored by session attendance logs. The practical module will be a group session, delivered by experts in pulmonary rehabilitation. It is estimated to that practical module will be a single 3-4 hour session. The maximum participants to facilitator ratio will be 3:1. The practical module will focus on practical aspects of content from the online program, including: • Performing exercise capacity tests • Exercise prescription Participants will be followed up 3-months after completing the training, prior to commencing Part Two of the study. Part two: Patient participants in the intervention group will undertake twice weekly PR at an allocated physiotherapy / exercise physiology practice for 8-weeks. After Visit 1 is completed, participants will be booked into the next available spot in the PR program. Private practice PR programs can be rolling or cohort programs with a minimum of 3 and a maximum of 8 participants in any one cohort. There should not be more than 2 weeks between Visit 1 and the commencement of the intervention. PR sessions will follow the Australian and New Zealand Pulmonary Rehabilitation guidelines and consist of at a minimum 30 minutes of lower limb endurance training, strength training and a home exercise program. Physiotherapists or AEPs delivering the intervention will prescribe each participant’s exercise program for each PR session in accordance with the current evidence-based practice guidelines. As per the training clinician participants were given in Part one of the study, participants will be prescribed lower limb endurance exercise intensity based on their baseline exercise capacity assessment. Intensity will be progressed throughout the intervention based on symptoms (measured by Borg dyspnoea scale). Upper and lower limb strength exercises will be prescribed from symptoms, measured by Borg scale. Exact exercises will be left to the physiotherapist or AEPs discretion and will consider existing exercise equipment at their practice, participant goals and past medical history. All intervention sessions must contain a walking exercise component, either treadmill walking or ground walking. Other examples of exercises may be stationary cycling, upper and lower limb strengthening exercises using resistance bands or free weights. Clinicians must document the mode, duration, intensity, type, and progression for each exercise prescribed. Frequency should be defined in the home exercise program. The home exercise program will be individualised and progressive. Home exercise programs will be performed at a minimum of once per week, the content of the home exercise program will be determined by the treating clinician. Session attendance logs and participant exercise logs will be used to monitor intervention fidelity.

Sponsors

University of Sydney
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Clinician participants: • AHPRA registered physiotherapist or Exercise & Sports Science Australia accredited exercise physiologist • Working in private practice where: o At least two staff (clinical or administrative) are present during assessments or group exercise sessions o There is adequate space for group exercise (minimum 3 participants) to occur o Accessible for people with chronic respiratory disease • Willing to provide intervention for part two of study (twice weekly PR for 8-weeks) • Have or be willing to obtain current CPR training prior to assessing any study participants Patient participants: • Age greater than 18 years • Diagnosis of COPD (confirmed by spirometry or diagnosis by medical doctor, symptomatically breathless and smoking history) or diagnosis of interstitial lung disease (ILD) (diagnosis by medical doctor) • Referred to pulmonary rehabilitation at Sydney Local Health District, South Eastern Sydney Local Health District or South Western Sydney Local Health District and on the waiting list • Willing to attend twice weekly PR for 8 weeks in a private practice setting

Exclusion criteria

Clinician participants: • Physiotherapists or AEPs with significant prior PR experience (more than one rotation as Level 1 clinician, or delivery of Lungs in Action) • Physiotherapists or AEPs with post-graduate cardiopulmonary qualifications Patient participants: • Exacerbation of respiratory disease within 4 weeks prior to recruitment • Completed PR in the past year • Prescribed home supplemental oxygen or requiring supplemental oxygen for exercise (desaturates < 80% SpO2 on field walking test) • Medical conditions that contraindicate safe group exercise outside hospital setting (e.g. unstable cardiac disease, severe musculoskeletal impairments) • Unable to provide informed consent

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 17, 2026